Trial intelligence / Profile preview

Coasting versus cabergoline for prevention of severe early OHSS in ART cycles

IRCT138706091132N1Phase 2Completed

Sponsor
Research and Clinical Center for Infertility
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cabergoline in ovarian hyperstimulation syndrome (OHSS), sponsored by Research and Clinical Center for Infertility. Started Jul 2006; status: completed.

02

Drugs

cabergoline
03

Conditions

ovarian hyperstimulation syndrome (OHSS)

Beyond the preview

Go deeper on IRCT138706091132N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138706091132N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call